(Q50703377)

17 March 2018

title

Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation. (English)

1 reference

17 March 2018

1 reference

Pamala Jacobson

1

1 reference

17 March 2018

Kathleen Green

2

1 reference

17 March 2018

John Rogosheske

3

1 reference

17 March 2018

Claudio Brunstein

4

1 reference

17 March 2018

Breta Ebeling

5

1 reference

17 March 2018

Todd DeFor

6

1 reference

17 March 2018

Philip McGlave

7

1 reference

17 March 2018

Daniel Weisdorf

8

1 reference

17 March 2018

publication date

1 January 2007

1 reference

17 March 2018

The Journal of Clinical Pharmacology

published in

1 reference

17 March 2018

volume

47

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

page(s)

6-12

1 reference

17 March 2018

Mycophenolate mofetil and its mechanisms of action

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Clinical pharmacokinetics of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Mycophenolate mofetil in islet cell transplant: variable pharmacokinetics but good correlation between total and unbound concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

The effect of selective bowel decontamination on the pharmacokinetics of mycophenolate mofetil in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295064

21 January 2018

Identifiers

DOI

10.1177/0091270006295064

1 reference

17 March 2018

release_wfqun7qra5a3ffihzhhstyxswi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wfqun7qra5a3ffihzhhstyxswi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 March 2018